Mammomat Revelation

2017-11-26

Mammomat Revelation
Mammomat Revelation

Nov 26, 2017

The new Mammomat Revelation also provides automated breast density measurements at the point of examination. This allows for personalized risk stratification and necessary adjunct imaging exams can be triggered before the patient leaves.

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.

Mammomat Revelation's current FDA approval status is currently "510k pending".

Reference Number: IM2017110126HCEN